In contrast, no association between FGFR4/FGF19 co-expression and EGFR or p53 was observed, suggesting that FGFR4/FGF19 might mediate cancer cell survival through a mechanism independent of EGFR or p53 signaling. The gene discussed is TP53; the disease is cancer.